Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans

Journal of Cardiovascular Pharmacology

Volumn 15, Issue , 1990, Pages S46-S56

  Bonner G ^a   Preis, S ^a   Schunk, U ^a   Toussaint, C ^a   Kaufmann, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Blood pressure; Bradykinin; Hypertension; Kallikrein kinin system; Prostaglandins; Pulmonary circulation

Indexed keywords

ANGIOTENSIN I; BRADYKININ; CAPTOPRIL; INDOMETACIN; KETOTIFEN; KETOTIFEN FUMARATE; LISINOPRIL; PROPRANOLOL; PROSTAGLANDIN; RAMIPRIL;

BLOOD PRESSURE; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HEMODYNAMICS; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; LUNG CIRCULATION; NORMAL HUMAN; PATIENT; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; VOLUNTEER;

ADULT; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BRADYKININ; CAPTOPRIL; CARDIAC OUTPUT; ENALAPRIL; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGE; PULMONARY CIRCULATION; SUPPORT, NON-U.S. GOV'T; VASCULAR RESISTANCE;

EID: 0025321098     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199000156-00010     Document Type: Article

References (33)

1. Bönner G. Kallikrein. In: Ganten D, Ritz E. eds. Lehrbuch der Hypertonie Stuttgart: Schattaucr-Verlag. 1985:231-42.
2. Carretero OA. Scicli AG. The renal kallikrein-kinin system. Am J Physiol 1980;238:F247-55.
3. Erdös EG. Bradykinin, kallidin and kallikrein. Handb Exp Pharmacol 1979:25.
4. Heidenreich O. Keller P. Kook Y. Die Wirkungen von Bradykinin und Kallidin auf die Nierenfunktion des Hundes. Naunyn Schmiedebergs Arch Pharmacol 1964;247:243-53.
5. Webster ME. Gilmore JP. Influence of kallidin-10 on renal function. Am J Physiol 1964;206:714-8.
6. Bishop JM, Harris P. Segel N. The circulatory effects of bradykinin in normal subjects and patients with chronic bronchitis. Br J Pharmacol 1965:25:456-69.
7. De Freitas FM. Faraco EZ. De Azevedo DF. General circulatory actions induced by intravenous infusion of synthetic bradykinin in man. Circulation 1964:29:66-70.
8. De Freitas FM. Faraco EZ. De Azevedo DF. Lewin I. Action of bradykinin on human pulmonary circulation. Observations in patients with mitral valvular disease. Circulation 1966: 34:385-90.
9. Lippton HL. Nandiwada PA. Hyman AL. Kadowitz PJ. Influence of cyclooxygenase blockade on responses to isoproterenol, bradykinin and nitroglycerin in the feline pulmonary vascular bed. Prostaglandins 1984;28:253-70.
10. Seeger W. Neuhof H, Graubert E. Wolf H, Roka L. Comparative influence of the Ca-ionophore A 23187. bradykinin, kallidin and eledoisin on the rabbit pulmonary vasculature with special reference to arachidonate metabolism. Adv Exp Med Biol 1983:156A:533-51.
11. Slocombe RF. Latter W. Derksen FJ, Robinson NE. Pulmonary response of neonatal calves to intravenous and aerosol bradykinin. Am J Vet Res 1982:43:2023-7.
12. Bönner G. Iwersen D. Shimamoto K. The analytical value for kinin concentration in blood depends on the antiserum used in the bradykinin radioimmunoassay. J Clin Chem Clin Biochem 1987:25:39-43.
13. Rasmussen S, Nielsen F. Ibsen H. Nielsen MD, Leth A, Giese J. Blood bradykinin concentration remains unchanged during Captopril treatment. Agents Actions 1982:suppl 9:592-7.
14. Shimamoto K, Iimura O. Measurement of circulating kinins, their changes by inhibition of kininase II and their possible blood pressure lowering effect. Agents Actions 1987;suppl 22:297-307.
15. Benetos A. Gavras H. Stewart JM. Vavrek R. Hatinoglu S, Gavras I. The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonist. Agents Actions 1987;suppl 22:355-64.
16. Barbey K. Barbey P. Ein neuer Plethysmograph zur Messung der Extremitätenpulse. Z Kreislforsch 1963:52:1129.
17. Bönner G. Marin-Grez M. Measurement of kallikrein activity in urine of rats and man using a chromigenic tripeptide substrate. J Clin Chem Biochem 1981:19:165-8.
18. Ryan JW, Chung A, Ammons C, Carlton ML. A simple radioassay for angiotensin-converting enzyme. Biochem J 1977:167:501-4.
19. Orstavik TB. Carretero OA, Johansen L. Scicli AG. Role of kallikrein in the hypotensive effect of Captopril after sympathetic stimulation of the rat submandibular gland. Circ Res 1982:51:385-90.
20. Regoli D, Mizrahi J. D'Orleans-Juste P, Caranikas S. Effects of kinins on isolated blood vessels. Role of endothelium. Can J Physiol Pharmacol 1982:60:1580-3.
21. Rhaleb NE. Dion S. Barabe J, et al. Receptors for kinins in isolated arterial vessels of dogs. Eur J Pharmacol 1989:162:419-27.
22. Yasujima M. Matthews PG. Johnston CI. Abe K. Yoshinaga K. Influence of low sodium diets on vascular effects of bradykinin and on bradykinin receptors in the uterine smooth muscle in the rats. Jpn Circ J 1982:46:540-3.
23. Thomas GR. Thiemermann C. Walder C, Vane JR. The effects of endothelium-dependent vasodilators on cardiac output and their distribution in the anaesthetized rat: a comparison with sodium nitroprusside. Br J Pharmacol 1988:95:986-92.
24. Fazekas A, Posch E. Zelles T. Effect of indomethacin on the bradykinin-induced vasodilation in the submandibular gland. Res Exp Med 1985:185:319-23.
25. Colman RW. Schapira M, Scott CF. Regulation of the formation and inhibition of human plasma kallikrein. Ann NY Acad Sci 1981:370:261-70.
26. De Oliveira Salgado MC. Krieger EM. Hyperreactivity to bradykinin and alterations in angiotensin 1 conversion and bradykinin inactivation in renal hypertensive rats. Hypertension 1982;4:77-83.
27. Tsuru H. Heterogeneity of the vascular effects of bradykinin. In: Vanhoutte PM. ed. Vasodilatation: vascular smooth muscle peptides, autonomic nerves, and endothelium. New York: Raven Press. 1988:479-82.
28. Innis RB. Manning DC, Stewart JM, Snyder SH. 3H-Brady-kinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci USA 1981:78:2630-4.
29. Bönner G. Haben die Kinine eine Bedeutung für die antihypertensive Wirkung der ACE-Hemmer? Z Kardiol 1988; 77(suppl 3):23-7.
30. Carretero OA. Scicli AG. The renal kallikrein-kinin system in human and in experimental hypertension. Klin Wochenschr 1978:56(suppl I):113-26.
31. Margolius HS. Geller R, Pisano JJ, Sjoerdsma A. Altered urinarv kallikrein excretion in human hypertension. Lancet 1971:2:1063-5.
32. Finkelstein SM. Collins VR. Cohn JN. Arterial vascular compliance response to vasodilators by Fourier and pulse contour analysis. Hypertension 1988:12:380-7.
33. Schulte KL. Braun J. Meyer-Sabellek W. Wegscheider K. Gotzen R. Distler A. Functional versus structural changes of forearm vascular resistance in hypertension. Hypertension 1988:11:320-5.